The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cunningham, M. D.
Right arrow Articles by Darveau, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cunningham, M. D.
Right arrow Articles by Darveau, R. P.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2000, 164: 3255-3263.
Copyright © 2000 by The American Association of Immunologists

CD14 Employs Hydrophilic Regions to "Capture" Lipopolysaccharides

Mark D. Cunningham*, Robert A. Shapiro{ddagger}, Carrie Seachord*, Kent Ratcliffe{dagger}, Linda Cassiano{dagger} and Richard P. Darveau1

* Bristol-Myers Squibb Pharmaceutical Research Institute, Lawrenceville, NJ 08543; {dagger} Immunex Corp., Seattle, WA 98101; and Departments of {ddagger} Psychiatry and Behavioral Sciences and § Periodontics, University of Washington, Seattle, WA 98195

CD14 participates in the host innate inflammatory response to bacterial LPS obtained from Escherichia coli and other Gram-negative bacteria. Evidence from several laboratories suggests that different regions of the amino-terminal portion of the molecule may be involved in LPS binding. In this report a series of single-residue serine replacement and charge reversal mutations were generated to further elucidate the mechanism by which this protein may bind a multitude of different LPS ligands. Single-residue CD14 mutation proteins were examined for their ability to bind LPS obtained from E. coli, Porphyromonas gingivalis, and Helicobacter pylori and facilitate the activation of E-selectin from human endothelial cells. In addition, the single-residue CD14 mutation proteins were employed to perform monoclonal epitope-mapping studies with three LPS-blocking Abs that bound tertiary epitopes. Evidence that several different hydrophilic regions of the amino-terminal region of CD14 are involved in LPS binding was obtained. Epitope-mapping studies revealed that these hydrophilic regions are located on one side of the protein surface. These studies suggest that CD14 employs a charged surface in a manor similar to the macrophage scavenger receptor to "capture" LPS ligands and "present" them to other components of the innate host defense system.




This article has been cited by other articles:


Home page
J. Exp. Biol.Home page
K. A. Daly, C. Lefevre, K. Nicholas, E. Deane, and P. Williamson
CD14 and TLR4 are expressed early in tammar (Macropus eugenii) neonate development
J. Exp. Biol., April 15, 2008; 211(8): 1344 - 1351.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
Y. Zhao, K. Yokota, K. Ayada, Y. Yamamoto, T. Okada, L. Shen, and K. Oguma
Helicobacter pylori heat-shock protein 60 induces interleukin-8 via a Toll-like receptor (TLR)2 and mitogen-activated protein (MAP) kinase pathway in human monocytes
J. Med. Microbiol., February 1, 2007; 56(2): 154 - 164.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
J. Koraha, N. Tsuneyoshi, M. Kimoto, J.-F. Gauchat, H. Nakatake, and K. Fukudome
Comparison of Lipopolysaccharide-Binding Functions of CD14 and MD-2
Clin. Vaccine Immunol., November 1, 2005; 12(11): 1292 - 1297.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-I. Kim, C. J. Lee, M. S. Jin, C.-H. Lee, S.-G. Paik, H. Lee, and J.-O. Lee
Crystal Structure of CD14 and Its Implications for Lipopolysaccharide Signaling
J. Biol. Chem., March 25, 2005; 280(12): 11347 - 11351.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
S.-N. Lin, K. Ayada, Y. Zhao, K. Yokota, R. Takenaka, H. Okada, R. Kan, S. Hayashi, M. Mizuno, Y. Hirai, et al.
Helicobacter pylori heat-shock protein 60 induces production of the pro-inflammatory cytokine IL8 in monocytic cells
J. Med. Microbiol., March 1, 2005; 54(3): 225 - 233.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
R. Takenaka, K. Yokota, K. Ayada, M. Mizuno, Y. Zhao, Y. Fujinami, S.-N. Lin, T. Toyokawa, H. Okada, Y. Shiratori, et al.
Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells
Microbiology, December 1, 2004; 150(12): 3913 - 3922.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R Arroyo-Espliguero, P Avanzas, S Jeffery, and J C Kaski
CD14 and toll-like receptor 4: a link between infection and acute coronary events?
Heart, September 1, 2004; 90(9): 983 - 988.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. B. Mizel, A. P. West, and R. R. Hantgan
Identification of a Sequence in Human Toll-like Receptor 5 Required for the Binding of Gram-negative Flagellin
J. Biol. Chem., June 20, 2003; 278(26): 23624 - 23629.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
G. Hajishengallis, M. Martin, R. E. Schifferle, and R. J. Genco
Counteracting Interactions between Lipopolysaccharide Molecules with Differential Activation of Toll-Like Receptors
Infect. Immun., December 1, 2002; 70(12): 6658 - 6664.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Muroi, T. Ohnishi, and K.-i. Tanamoto
Regions of the Mouse CD14 Molecule Required for Toll-like Receptor 2- and 4-mediated Activation of NF-kappa B
J. Biol. Chem., October 25, 2002; 277(44): 42372 - 42379.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
V. J. McCracken, T. Chun, M. E. Baldeon, S. Ahrne, G. Molin, R. I. Mackie, and H. R. Gaskins
TNF-{alpha} Sensitizes HT-29 Colonic Epithelial Cells to Intestinal Lactobacilli
Experimental Biology and Medicine, September 1, 2002; 227(8): 665 - 670.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Ismaili, J. Rennesson, E. Aksoy, J. Vekemans, B. Vincart, Z. Amraoui, F. Van Laethem, M. Goldman, and P. M. Dubois
Monophosphoryl Lipid A Activates Both Human Dendritic Cells and T Cells
J. Immunol., January 15, 2002; 168(2): 926 - 932.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. Watanabe, O. Yilmaz, S. F. Nakhjiri, C. M. Belton, and R. J. Lamont
Association of Mitogen-Activated Protein Kinase Pathways with Gingival Epithelial Cell Responses to Porphyromonas gingivalis Infection
Infect. Immun., November 1, 2001; 69(11): 6731 - 6737.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. I. Song, T. A. Abraham, Y. Park, A. S. Zivony, B. Harten, H. F. Edelhauser, S. L. Ward, C. A. Armstrong, and J. C. Ansel
The Expression of Functional LPS Receptor Proteins CD14 And Toll-Like Receptor 4 in Human Corneal Cells
Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 2867 - 2877.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Hirschfeld, J. J. Weis, V. Toshchakov, C. A. Salkowski, M. J. Cody, D. C. Ward, N. Qureshi, S. M. Michalek, and S. N. Vogel
Signaling by Toll-Like Receptor 2 and 4 Agonists Results in Differential Gene Expression in Murine Macrophages
Infect. Immun., March 1, 2001; 69(3): 1477 - 1482.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. Dziarski, S. Viriyakosol, T. N. Kirkland, and D. Gupta
Soluble CD14 Enhances Membrane CD14-Mediated Responses to Peptidoglycan: Structural Requirements Differ from Those for Responses to Lipopolysaccharide
Infect. Immun., September 1, 2000; 68(9): 5254 - 5260.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. da Silva Correia and R. J. Ulevitch
MD-2 and TLR4 N-Linked Glycosylations Are Important for a Functional Lipopolysaccharide Receptor
J. Biol. Chem., January 11, 2002; 277(3): 1845 - 1854.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.